Crinetics Pharmaceuticals CRNX Business Segments — Total other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's business segments — total other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's business segments — total other income, net?
- Crinetics Pharmaceuticals (CRNX) reported business segments — total other income, net of $12.53M in Q1 2026.
- How has Crinetics Pharmaceuticals's business segments — total other income, net changed year-over-year?
- Crinetics Pharmaceuticals's business segments — total other income, net decreased by 14.3% year-over-year, from $14.63M to $12.53M.
- What does business segments — total other income, net mean?
- Includes non-operating income and expenses, such as interest income from cash reserves, foreign exchange gains or losses, and other miscellaneous financial items. This metric provides insight into the company's financial management outside of its core pharmaceutical research and commercial activities. It is a key component of the company's overall net financial position.